|
2008
|
Invention
|
Amino tricyclic-nucleoside compounds, compositions, and methods of use. Provided are compounds of... |
|
|
Invention
|
Nitrogen containing bicyclic chemical entities for treating viral infections. Provided are certai... |
|
|
Invention
|
Anti-viral inhibitors and methods of use. Disclosed are compounds and compositions of Formula (I)... |
|
2007
|
Invention
|
Tricyclic-nucleoside compounds for treating viral infections.
Disclosed are tricyclic nucleoside... |
|
|
Invention
|
Polycyclic viral inhibitors. Disclosed are compounds and compositions of Formula (A) and their us... |
|
|
Invention
|
Antiviral agents. Disclosed are compounds and compositions of Formula (I) and their uses for trea... |
|
|
Invention
|
Antiviral agents. Disclosed are compounds and compositions of Formula, (I) and their uses for tre... |
|
2006
|
Invention
|
N-(5-membered heteroaromatic ring)-amido anti-viral compounds. Disclosed are compounds having For... |
|
|
Invention
|
N-(6-membered aromatic ring)-amido anti-viral compounds. Disclosed are compounds having Formula (... |
|
|
Invention
|
Nucleoside compounds for treating viral infections.
Disclosed are compounds, compositions and me... |
|
|
Invention
|
6-membered aryl and heteroaryl derivatives for the treatment of hepatitis c virus. Disclosed are ... |
|
|
Invention
|
Heteroaryl derivatives for treating viruses. Disclosed are compounds, compositions, and methods f... |
|
|
Invention
|
Nucleoside compounds for treating viral infections. Disclosed are compounds of formula I1 composi... |
|
|
Invention
|
Nucleoside prodrugs for treating viral infections. Disclosed are prodrug compoundsand their compo... |
|
|
Invention
|
Nucleoside prodrugs for treating viral infections. Disclosed are prodrug compounds of Formula I, ... |
|
|
Invention
|
Dhea composition and method.
Disclosed are improved pharmaceutical formulations comprising dehyd... |
|
|
Invention
|
Tricyclic-nucleoside compounds for treating viral infections. Disclosed are compounds represented... |
|
|
Invention
|
Tricyclic-nucleoside compounds for treating viral infections. Disclosed are tricyclic nucleoside ... |
|
|
Invention
|
Tricyclic-nucleoside prodrugs for treating viral infections. This invention is directed to novel ... |
|
|
Invention
|
Indole derivatives for treating viral infections. Disclosed are compounds having formula I and re... |
|
2005
|
Invention
|
5-nitro-nucleoside compounds for treating viral infections. Disclosed are compounds, compositions... |
|
|
Invention
|
Nucleoside derivatives for treating hepatitis c virus infection. Disclosed are adenosine derivati... |
|
|
Invention
|
Nucleoside derivatives for treating hepatitis c virus infection. Disclosed are compounds, composi... |
|
2004
|
Invention
|
Treatment of subnormal bone mineral density. A method of treating an individual to increase the i... |
|
|
Invention
|
Nucleoside compounds for treating viral infections. Disclosed are compounds, compositions and met... |
|
|
Invention
|
Methods for preparing 7-(2'-substituted-.szlig.-d-ribofuranosyl)-4-(nr2r3)-5-(substituted ethyn-1... |
|
|
Invention
|
Methods for preparing 7-(2'-substituted-ß-d-ribofuranosyl)-4-(nr2r3)-5-(substituted et... |
|
|
Invention
|
Bicyclic imidazol derivatives against flaviviridae. Disclosed are compounds, compositions and met... |
|
|
Invention
|
Modulation of interleukin-10 by dhea. Methods of modulating IL-10 levels in a subject through adm... |
|
|
Invention
|
Nitrogen-containing heteroaryl derivatives for the treatment of hcv-infection. Disclosed are comp... |
|
2003
|
Invention
|
Novel aromatic compounds possessing antifungal or antibacterial activity. The present invention p... |
|
|
Invention
|
Aryl and heteroaryl compounds as antibacterial and antifungal agents. This invention provides nov... |
|
|
Invention
|
Transcripts encoding immunomodulatory polypeptides. Substantially-isolated polynucleotides encodi... |
|
|
Invention
|
Treatment of sle with dehydroepiandrosterone. This invention provides a method of treating system... |
|
2002
|
Invention
|
Polyamide derivatives possessing antibacterial, antifungal or antitumor activity. The present inv... |
|
|
Invention
|
Hepatitis e virus vaccine and method. Antigen and antibody vaccine composition effective in preve... |
|
2001
|
Invention
|
Sequence-directed dna-binding molecules compositions and methods. The present invention defines a... |
|
2000
|
Invention
|
Dhea composition and method. Disclosed are improved pharmaceutical formulations comprising dehydr... |
|
|
Invention
|
Dna binding compound-mediated molecular switch system. The present invention provides molecular s... |
